Lexeo Therapeutics Inc (LXEO)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-19 | S Sale |
Chief Executive Officer Executive Director |
4,326
-1.9%
4.41USD 19,091 |
4,326 -1.9% | 4.41 | USD 19,091 | |
| 2025-02-21 | 2025-02-19 | S Sale |
Chief Legal Officer Officer |
2,101
-3.5%
4.41USD 9,272 |
2,101 -3.5% | 4.41 | USD 9,272 | |
| 2025-02-21 | 2025-02-19 | S Sale |
Chief Development Officer Officer |
1,486
-2.7%
4.41USD 6,558 |
1,486 -2.7% | 4.41 | USD 6,558 | |
| 2025-02-21 | 2025-02-19 | S Sale |
Chief Medical Officer Officer |
2,359
-3.3%
4.41USD 10,410 |
2,359 -3.3% | 4.41 | USD 10,410 | |
| 2024-12-12 | 2024-12-10 | PS Planned sale |
Chief Executive Officer Executive Director |
2,500
-2.0%
8.20USD 20,491 |
2,500 -2.0% | 8.20 | USD 20,491 | |
| 2024-11-26 | 2024-11-25 | B Purchase | Non-Executive Director |
15,000
+96.0%
6.99USD 104,852 |
15,000 +96.0% | 6.99 | USD 104,852 | |
| 2024-11-13 | 2024-11-11 | PS Planned sale |
Chief Executive Officer Executive Director |
2,500
-2.0%
7.82USD 19,557 |
2,500 -2.0% | 7.82 | USD 19,557 | |
| 2024-10-15 | 2024-10-10 | PS Planned sale |
Chief Executive Officer Executive Director |
5,000
-4.0%
8.10USD 40,496 |
5,000 -4.0% | 8.10 | USD 40,496 | |
| 2024-09-11 | 2024-09-10 | PS Planned sale |
Chief Executive Officer Executive Director |
5,000
-4.0%
10.65USD 53,274 |
5,000 -4.0% | 10.65 | USD 53,274 | |
| 2024-08-13 | 2024-08-12 | PS Planned sale |
Chief Executive Officer Executive Director |
5,000
-4.0%
11.53USD 57,635 |
5,000 -4.0% | 11.53 | USD 57,635 | |
| 2024-07-12 | 2024-07-11 | PS Planned sale |
Chief Executive Officer Executive Director |
100
-0.1%
19.06USD 1,906 |
100 -0.1% | 19.06 | USD 1,906 | |
| 2024-07-12 | 2024-07-11 | PS Planned sale |
Chief Executive Officer Executive Director |
27,931
-18.8%
17.06USD 476,503 |
27,931 -18.8% | 17.06 | USD 476,503 | |
| 2024-07-12 | 2024-07-10 | PS Planned sale |
Chief Executive Officer Executive Director |
3,347
-2.2%
16.85USD 56,397 |
3,347 -2.2% | 16.85 | USD 56,397 | |
| 2024-07-12 | 2024-07-10 | PS Planned sale |
Chief Executive Officer Executive Director |
23,622
-13.4%
16.45USD 388,582 |
23,622 -13.4% | 16.45 | USD 388,582 | |
| 2024-06-12 | 2024-06-10 | PS Planned sale |
Chief Executive Officer Executive Director |
2,038
-1.2%
18.18USD 37,051 |
2,038 -1.2% | 18.18 | USD 37,051 | |
| 2024-06-12 | 2024-06-10 | PS Planned sale |
Chief Executive Officer Executive Director |
2,962
-1.7%
17.29USD 51,213 |
2,962 -1.7% | 17.29 | USD 51,213 | |
| 2024-05-14 | 2024-05-13 | PS Planned sale |
Chief Executive Officer Executive Director |
5,000
-2.8%
13.22USD 66,093 |
5,000 -2.8% | 13.22 | USD 66,093 | |
| 2023-11-09 | 2023-11-07 | B Purchase |
Longitude Capital Partners IV, LLC Large shareholder |
454,545
+21.5%
11.00USD 4,999,995 |
454,545 +21.5% | 11.00 | USD 4,999,995 | |
| 2023-11-09 | 2023-11-07 | B Purchase | Large shareholder |
454,545
+26.7%
11.00USD 4,999,995 |
454,545 +26.7% | 11.00 | USD 4,999,995 | |
| 2023-11-09 | 2023-11-07 | B Purchase | Large shareholder |
227,272
+14.1%
11.00USD 2,499,992 |
227,272 +14.1% | 11.00 | USD 2,499,992 |